Center for Immunization Research - Johns Hopkins Bloomberg School of Public Health
Baltimore, Maryland 21205
We've found
4 trials
at this facility
Ebola Virus Disease Clinical Trial
Updated: 12/31/1969
Evaluating the Live-Attenuated Human Parainfluenza Virus Type 3 Vectored Vaccine Candidate Expressing Ebolavirus Zaire Glycoprotein as the Sole Envelope Glycoprotein
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Influenza Clinical Trial
Updated: 12/31/1969
Immunogenicity and Safety Study of Inactivated Subunit H5N1 Influenza Vaccine in Prior Recipients of Live Attenuated H2N2, H6N1 and H9N2 Influenza Vaccines and in H5N1 and Live Attenuated Vaccine Naïve Individuals
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Respiratory Syncytial Virus Infections Clinical Trial
Updated: 12/31/1969
Evaluating the Infectivity, Safety, and Immunogenicity of the Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV ΔNS2/Δ1313/I1314L or RSV 276 in RSV-Seronegative Infants and Children 6 to 24 Months of Age
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
RSV Infection Clinical Trial
Updated: 12/31/1969
Evaluating the Infectivity, Safety, and Immunogenicity of a Respiratory Syncytial Virus Vaccine (RSV 6120/∆NS2/1030s) in RSV-Seropositive Children and RSV-Seronegative Infants and Children
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials